Drug efficacy on zoonotic nematodes of the Anisakidae family: new metabolic data

Parasitology. 2022 Jul;149(8):1065-1077. doi: 10.1017/S0031182022000543. Epub 2022 Apr 21.

Abstract

In the Anisakidae family, there are nematodes, most of which are parasitic for important commercial fish species. Both public health risks and socio-economic problems are attributed to these parasites. Despite these concerns, knowledge of the metabolism of these parasites remains unknown. Therefore, the main objective of this study was to investigate the receptors of drugs and oxidative metabolic status of two Anisakidae species, Pseudoterranova decipiens (s. s.) and Contracaecum osculatum (s. s.), under the influence of anthelminthic drugs, ivermectin (IVM) and pyrantel (PYR), at different concentrations: 1.56, 3.125 and 6.25 μg mL−1 of culture medium for 3, 6, 9, 12 and 72 h. The mRNA expressions of the γ-aminobutyric acid receptor, acetylcholine receptor subunits, adenosine triphosphate-binding cassette transporters and antioxidative enzymes were determined. The total antioxidant capacity and glutathione S-transferase activity were also examined. To the best of the authors' knowledge, this is the first time that IVM and PYR have been tested against these parasitic nematodes.

Keywords: Anisakidae; drug receptors; ivermectin; oxidative stress; parasitic nematode; pyrantel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ascaridoidea* / genetics
  • Fish Diseases* / parasitology
  • Fishes / parasitology